GGrantIndex
← Leaderboards

Thomas R Hawn

University Of Washington

$19,135,026
Attributed
$35,536,454
Total exposure
17
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.9M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$48,523,059 · 18

By mechanism

R01$20,714,699 · 4
U19$16,067,079 · 3
R33$3,421,750 · 1
R61$2,121,066 · 1
K24$1,637,792 · 2
D43$1,438,418 · 1

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisMycobacterium TuberculosisMacrophageResponseInfectionVaccinesVariantFollow-UpPathogenesisCohortInsightPathogenPredispositionPathway InteractionsGenesProgramsCellsResistanceGenetic VariantPulmonary TuberculosisHuman GeneticsPharmaceutical PreparationsResistance MechanismMonocyte

Grant awards (71)

Host Pathogen Variation & TB Pathogenesis$2,209,347
U19 · FY2025 · AI · contact PI
Human macrophage variation & TB pathogenesis$367,811
U19 · FY2025 · AI · contact PI
Development Core$327,075
P30 · FY2025 · AI · contact PI
Tuberculosis & HIV Co-Infection Training Program in Kenya$286,554
D43 · FY2025 · TW · contact PI
Host Pathogen Variation & TB Pathogenesis$210,900
U19 · FY2025 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$158,490
U19 · FY2025 · AI · contact PI
Administrative Core$122,939
U19 · FY2025 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$1
U19 · FY2025 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$2,583,647
U19 · FY2024 · AI · contact PI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission$650,953
R01 · FY2024 · AI
Human macrophage variation & TB pathogenesis$515,345
U19 · FY2024 · AI · contact PI
Development Core$355,427
P30 · FY2024 · AI · contact PI
Tuberculosis & HIV Co-Infection Training Program in Kenya$286,730
D43 · FY2024 · TW · contact PI
Administrative Core$152,452
U19 · FY2024 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$2,599,143
U19 · FY2023 · AI · contact PI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts$750,333
R01 · FY2023 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission$747,406
R01 · FY2023 · AI
Human macrophage variation & TB pathogenesis$449,889
U19 · FY2023 · AI · contact PI
Development Core$419,170
P30 · FY2023 · AI · contact PI
Tuberculosis & HIV Co-Infection Training Program in Kenya$286,900
D43 · FY2023 · TW · contact PI
Administrative Core$181,990
U19 · FY2023 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$2,586,191
U19 · FY2022 · AI · contact PI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts$1,177,109
R01 · FY2022 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection$1,080,143
R33 · FY2022 · AI · contact PI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission$733,901
R01 · FY2022 · AI
Human macrophage variation & TB pathogenesis$499,471
U19 · FY2022 · AI · contact PI
Tuberculosis & HIV Co-Infection Training Program in Kenya$287,132
D43 · FY2022 · TW · contact PI
Development Core$223,704
P30 · FY2022 · AI · contact PI
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection$176,343
K24 · FY2022 · AI · contact PI
Administrative Core$146,908
U19 · FY2022 · AI · contact PI
Host Pathogen Variation & TB Pathogenesis$2,638,886
U19 · FY2021 · AI · contact PI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection$1,319,833
R33 · FY2021 · AI · contact PI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts$695,679
R01 · FY2021 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission$693,648
R01 · FY2021 · AI
Human macrophage variation & TB pathogenesis$492,747
U19 · FY2021 · AI · contact PI
Tuberculosis & HIV Co-Infection Training Program in Kenya$291,102
D43 · FY2021 · TW · contact PI
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection$177,373
K24 · FY2021 · AI · contact PI
Administrative Core$150,922
U19 · FY2021 · AI · contact PI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa$1,853,980
R01 · FY2020 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection$1,021,774
R33 · FY2020 · AI · contact PI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts$972,111
R01 · FY2020 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission$705,533
R01 · FY2020 · AI
Molecular Medicine Training Program$253,018
T32 · FY2020 · GM
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection$178,442
K24 · FY2020 · AI · contact PI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa$2,270,572
R01 · FY2019 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection$1,043,172
R61 · FY2019 · AI · contact PI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts$726,648
R01 · FY2019 · AI
Molecular Medicine Training Program$249,752
T32 · FY2019 · GM
Non-tuberculous Mycobacteria & Heterologous Immunity$222,775
R21 · FY2019 · AI · contact PI
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection$179,469
K24 · FY2019 · AI · contact PI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa$2,422,204
R01 · FY2018 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection$1,077,894
R61 · FY2018 · AI · contact PI
Non-tuberculous Mycobacteria & Heterologous Immunity$285,935
R21 · FY2018 · AI · contact PI
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection$180,525
K24 · FY2018 · AI · contact PI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa$2,438,386
R01 · FY2017 · AI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa$2,292,400
R01 · FY2016 · AI
Innate Immunogenetics & Human Infections$148,389
K24 · FY2014 · AI · contact PI
CD180 and the Macrophage Response to Legionella pneumophila$193,125
R21 · FY2013 · AI · contact PI
Innate Immunogenetics & Human Infections$149,700
K24 · FY2013 · AI · contact PI
CD180 and the Macrophage Response to Legionella pneumophila$231,500
R21 · FY2012 · AI · contact PI
Innate Immunogenetics & Human Infections$149,700
K24 · FY2012 · AI · contact PI
Innate Immunogenetics & Human Infections$150,328
K24 · FY2011 · AI · contact PI
Innate Immunogenetics & Human Infections$147,523
K24 · FY2010 · AI · contact PI
TLR5 and Pulmonary Innate Immunity$305,579
R01 · FY2009 · AI · contact PI
TLR5 and Pulmonary Innate Immunity$305,579
R01 · FY2008 · AI · contact PI
TLR5 and Pulmonary Innate Immunity$311,497
R01 · FY2007 · AI · contact PI
TLR5 and Pulmonary Innate Immunity$321,113
R01 · FY2006 · AI · contact PI
TLR5 and Pulmonary Innate Immunity$340,068
R01 · FY2005 · AI
Toll-like Receptors and the Innate Immune Response$120,258
K08 · FY2003 · AI
Toll-like Receptors and the Innate Immune Response$120,258
K08 · FY2002 · AI
Toll-like Receptors and the Innate Immune Response$120,258
K08 · FY2001 · AI